These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3178171)

  • 41. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma.
    Bhatavdekar JM; Trivedi SN; Shah NG; Karelia NH; Patel DD; Giri DD; Patel TB
    Neoplasma; 1988; 35(4):413-23. PubMed ID: 3185838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating soluble Fas concentration in breast cancer patients.
    Ueno T; Toi M; Tominaga T
    Clin Cancer Res; 1999 Nov; 5(11):3529-33. PubMed ID: 10589768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.
    Hammond ME; Hayes DF; Wolff AC
    J Clin Oncol; 2011 May; 29(15):e458. PubMed ID: 21502545
    [No Abstract]   [Full Text] [Related]  

  • 45. [Estrogen receptor (ER), progesterone receptor (PR)].
    Sawada T; Sakayori N
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():762-4. PubMed ID: 16149634
    [No Abstract]   [Full Text] [Related]  

  • 46. Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment.
    Ben-David M; Kadar T; Wittliff J; Biran S; Schally A
    Biomed Pharmacother; 1988; 42(2):101-9. PubMed ID: 3167163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diminished ratio of estrogen receptors to progesterone receptors in breast carcinomas of women who have had multiple miscarriages.
    Lehrer S; Levine E; Savoretti P; Cropley J; Dalton J; Song HK; Thung SN; Rabinowitz J; Mandell L
    Mt Sinai J Med; 1992 Jan; 59(1):28-31. PubMed ID: 1734234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer.
    Glikman P; Vegh I; Pollina MA; Mosto AH; Levy CM
    Cancer; 1987 Nov; 60(9):2237-43. PubMed ID: 3440234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complex biochemical analysis of human breast tumor tissue.
    Lang BA; Cernoch M; Vermousek I; Simícková M; Stratil P; Rejthar A; Hlávková J; Sakalová J; Celý J
    Neoplasma; 1989; 36(1):61-9. PubMed ID: 2565021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disordered nocturnal prolactin regulation in women with breast cancer.
    Malarkey WB; Schroeder LL; Stevens VC; James AG; Lanese RR
    Cancer Res; 1977 Dec; 37(12):4650-4. PubMed ID: 922745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Estrogen and progesterone receptors].
    Sawada T; Sakayori N
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():799-802. PubMed ID: 20960876
    [No Abstract]   [Full Text] [Related]  

  • 53. Stage-dependent depression of melatonin in patients with primary breast cancer. Correlation with prolactin, thyroid stimulating hormone, and steroid receptors.
    Bartsch C; Bartsch H; Fuchs U; Lippert TH; Bellmann O; Gupta D
    Cancer; 1989 Jul; 64(2):426-33. PubMed ID: 2736489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma melatonin and the hormone-dependency of human breast cancer.
    Danforth DN; Tamarkin L; Mulvihill JJ; Bagley CS; Lippman ME
    J Clin Oncol; 1985 Jul; 3(7):941-8. PubMed ID: 4020407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating levels of prolactin in breast cancer patients.
    Mujagić Z; Mujagić H; Prnjavorac B
    Med Arh; 2005; 59(1):33-5. PubMed ID: 15822682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Concentration of estrogen and progesterone receptors in normal and neoplastic tissue in patients with laryngeal neoplasm].
    Piatkowski K; Kruk-Zagajewska A; Thielemann A; Kopczyński Z
    Otolaryngol Pol; 2002; 56(4):445-50. PubMed ID: 12378804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer.
    Holtkamp W; Nagel GA; Wander HE; Rauschecker HF; von Heyden D
    Int J Cancer; 1984 Sep; 34(3):323-8. PubMed ID: 6480153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of bromocriptin treatment on prolactin and steroid receptor levels in human breast cancer.
    Peyrat JP; Vennin P; Bonneterre J; Hecquet B; Vandewalle B; Kelly PA; Djiane J
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1363-7. PubMed ID: 6094194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen and progesterone receptors in breast cancer.
    Vihko R; Isotalo H
    Acta Obstet Gynecol Scand Suppl; 1981; 101():29-35. PubMed ID: 6946669
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
    Barni S; Lissoni P; Paolorossi F; Crispino S; Rovelli F; Ferri L; Sormani A; D'Alonso U; Bugatti A; Nociti V
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1141-5. PubMed ID: 3653210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.